✦ LIBER ✦

Phase II study of an intensive single dose of irinotecan (CPT-11) and cisplatin (CDDP) every three weeks, in patients with advanced non-small cell lung cancer

✍ Scribed by Dómine, M; Cardenal, F; Massuti, B; Carrato, A; Felip, E; Garrido, P; Juan, O; Artal, A; Barneto, I; Lopez-Vivanco, G; Rosell, R; Balcells, M; Gonzalez, J

Book ID: 118569723
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 141 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80178-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of irinotecan (CPT-11) and

Phase I study of irinotecan (CPT-11) and cisplatin (CDDP) combination in metastatic non-small cell lung cancer (NSCLC)

✍ Kakolyris, S; Kouroussis, C; Souglakos, J; Androulakis, N; Mavroudis, D; Kalbaki 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Phase I study of irinotecan (CPT-11) and

Phase I study of irinotecan (CPT-11) and cisplatin (CDDP) with concurrent thoracic radiotherapy (TRT) in locally advanced non-small cell lung cancer (NSCLC)

✍ Nakamura, Y; Fukuda, M; Fukuda, Mi; Soda, H; Ichiki, M; Takatani, H; Kanda, T; K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Fractionated administration of cisplatin

Fractionated administration of cisplatin (CDDP) and irinotecan (CPT-11) in patients with stage IIIB and IV non-small-cell lung cancer (NSCLC): A phase II study

✍ Takata, I; Ueoka, H; Kiura, K; Hiraki, S; Eguchi, K; Okimoto, N; Harita, S; Yone 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Three-week schedule of irinotecan and ci

Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study

✍ Cardenal, F 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 120 KB

P-528 A phase II study of weekly irinite

P-528 A phase II study of weekly irinitecan (CPT-11) plus cisplatin (CDDP) in previously untreated patients with advanced non-small cell lung cancer (NSCLC)

✍ Nakanishi, Yoichi; Ninomiya, Kiyoshi; Kawasaki, Masayuki; Yamasaki, Hiroshi; Tak 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

The final results of a randomized phase

The final results of a randomized phase III trial comparing irinotecan (CPT-11) and cisplatin (CDDP) with vindesine (VDS) and CDDP in advanced non-small cell lung cancer (NSCLC)

✍ Takiguchi, Y; Nagao, K; Nishiwaki, Y; Yokoyama, A; Saijo, N; Ohashi, Y; Niitani, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 219 KB